Myasthenic crisis in COVID-19

Fadi Delly, M. J. Syed, R. Lisak, D. Zutshi

Journal of the Neurological Sciences, 2020

Highlights • Myasthenic crises is a potentially severe complication of COVID-19.• Hydroxychloroquine can aggravate myasthenia crises.• IVIg is a potential treatment for both Myasthenic crises and COVID-19.• IVIg treatment may cause thrombosis in susceptible patients.

Cited by 35 publications.

Field of study: Medicine

10.1016/j.jns.2020.116888